glp-1 agonists and pancreatitis Enzyme Rise May Link GLP-1, Glucagon-like Peptide 1 Receptor Signaling

Limited Long-term Data : While short- to medium-term data are compelling, the long-term safety and efficacy profile over decades of treatment remains incompletely characterized

[DOI] [PMC free article] [PubMed] [Google Scholar] 92.Sadeghi A., Mousavi S.M., Mokhtari T., Parohan M., Milajerdi A

Once-weekly semaglutide in adults with overweight or obesity

Blood sugar management at the starting dose is generally favorable, but coordination with a healthcare provider who manages diabetes medications is important to prevent hypoglycemic events as retatrutide begins improving insulin sensitivity

Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, et al

Key policy areas that require attention include: Clinical Practice Guidelines : Development of standardized, evidence-based guidelines for the use of GLP-1 RAs in children and adolescents, including indications, dosing, and monitoring